Alaska Permanent Fund: Funding, Team & Investors | Startup Intros

Loading organizations...

Alaska Permanent Fund: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 1, 2024	Kenai Therapeutics	$82.0M Series A	Cure Ventures, The Column Group, Alaska Permanent Fund	Euclidean Capital, Saisei Ventures
Apr 1, 2022	Tessera Therapeutics	$300.0M Series C	—	Catalio Capital, Flagship Ventures, Petri, Abu Dhabi Investment Authority, Altitude Life Science Ventures, Cormorant Asset Management, Hanwha Impact, Longevity Vision Fund, March Capital, SALT Fund, Vali Barsan, T. Rowe Price Associates
Nov 1, 2021	Generate Biomedicines	$370.0M Series B	—	Alumni Ventures, Flagship Pioneering, Altitude Life Science Ventures, ARCH Venture Partners, T. Rowe Price Associates
Apr 1, 2021	Repertoire Immune Medicines	$190.0M Series B	Flagship Ventures	ARCH Venture Partners, F-Prime Capital Partners, Invus, PSP Investments, SoftBank
Jan 12, 2021	Tessera	$230.0M Series B	Alaska Permanent Fund, Altitude Life Science Ventures, SoftBank	Noubar Afeyan, Qatar Investment Authority
Aug 5, 2020	Indigo	$360.0M Series F	—	Flagship Pioneering
Aug 3, 2020	Indigo Agriculture	$360.0M Series F	—	Flagship Pioneering
Sep 18, 2018	Indigo	$250.0M Series E	—	Flagship Pioneering, Investment Corporation of Dubai
Dec 6, 2017	Indigo Agriculture	$203.0M Series D	—	Activant Capital, Flagship Pioneering, Mohammed I. Al Shaibani
Nov 29, 2017	Codiak Biosciences	$76.5M Series C	—	Alexandria Venture Investments, ARCH Venture Partners, Boxer Capital, Casdin Capital, EcoR1 Capital, Fidelity Management & Research Company, Flagship Pioneering, Qatar Investment Authority, Sirona Capital
Sep 26, 2017	Indigo	$156.0M Series D	—	Activant Capital, Flagship Pioneering
Jan 26, 2016	Codiak Biosciences	$61.0M Series B	ARCH Venture Partners, Flagship Ventures	Alexandria Venture Investments, Codiak BioSciences, Fidelity Management & Research Company
Nov 17, 2015	Codiak Biosciences	$80.0M Series A	Steven Gillis, Noubar Afeyan	Alexandria Venture Investments, Fidelity Management & Research Company
May 1, 2015	Denali Therapeutics	$220.0M Series A	—	ARCH Venture Partners, Borealis Ventures, Flagship Ventures, F-Prime Capital Partners, InterWest, Samsara BioCapital, Vivo Capital, Wildcat Ventures, Douglas Cole, Stephen Knight
Apr 24, 2014	Juno Bio	$176.0M Series A	Alaska Permanent Fund, ARCH Venture Partners	Bezos Expeditions, Venrock
Dec 1, 2013	Juno Therapeutics	$120.0M Series A	ARCH Venture Partners, Jeff Bezos, anthony Evnin, Mike Burns	Flagship Ventures